glp-1 surgery guidance news Metabolic and agonists | Blog New Guidance Suggests Most Patients

Because plans are commitment-based, the upfront cost on the longer plans is high (12-month total: $1,668)

The data: Most patients who got prescribed a GLP-1 for the first time in 2023 or 2024 ended up discontinuing treatment before long, and many never filled their prescription at all, according to a November 2025 IQVIA analysis of GLP-1 prescription claims

Gastrointestinal effects are the most common

A genetic map of the mouse dorsal vagal complex and its role in obesity

A literature review found that 200 mg/d of a standardized extract helps normalize the release of stress hormones while boosting energy metabolism (Anghelescu 2018)